Viewing Study NCT04990258

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:08 AM

Ignite Modification Date: 2025-12-25 @ 10:08 PM

Study NCT ID: NCT04990258

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2024-01-24

First Post: 2021-06-14

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module